Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Ovagen

Glu-Asp-Leu, Liver Bioregulator Peptide

Quick Stats
Studies 34
Trials 30
Score 1
2002 pubmed

Patterns of follicular growth in superovulated sheep and influence on endocrine and ovarian response.

Gonzalez-Bulnes. A A; Garcia-Garcia. R M RM; Souza. C J H CJ; Santiago-Moreno. J J; Lopez-Sebastian. A A; Cocero. M J MJ; Baird. D T DT

Key Findings

  • Ovagen caused a strong increase in follicles larger than 4 mm by speeding up their growth and reducing their loss.
  • More large follicles at the start of treatment were linked to earlier estrus behavior and earlier LH hormone surge.
  • Higher numbers of large follicles resulted in a higher ovulation count, but an earlier LH surge was associated with lower embryo recovery.

Practical Outcomes

  • For biohackers, the data show that Ovagen (FSH) can dramatically stimulate ovarian follicle development in sheep, but the timing of hormone peaks matters for successful embryo formation. The findings are specific to sheep reproduction and do not directly translate to human protocols for longevity, metabolism, or performance, so they have limited practical use for most self‑directed health experiments.

Summary

In a study on sheep, the FSH drug Ovagen boosted the number and growth of ovarian follicles, leading to earlier signs of heat and a higher number of eggs released, but it also caused fewer embryos to be recovered when the hormone surge happened too early.

Abstract

Objectives of this study were to characterize patterns of follicular development in sheep superovulated with purified follicle stimulating hormone (FSH) (OVAGEN, ICP, Auckland, New Zealand) and to determine its influence on preovulatory events (onset of the oestrus behaviour and timing of the preovulatory luteinizing hormone surge) and ovarian response (ovulation rate and embryo yield). Number and size of all >/= 23 mm follicles from the first FSH injection to withdrawal of progestagen sponges was determined by transrectal ultrasonography just prior to every FSH injection in nine Manchega ewes superovulated with eight decreasing doses (ml) (1.5 x 3, 1.25 x 2 and 1 x 3) of OVAGEN injected twice daily from 60 h before to 24 h after the withdrawal of 40 mg fluorogestone acetate sponges. Oestrous detection and jugular blood sampling for LH radioimmunoassay were performed every 3 h from 14 to 53 h after sponge removal and ovulation rate and number of embryos were determined 4 days after progestagen withdrawal. Administration of OVAGEN induced a significant rise (p < 0.0005) in the number of follicles >/= 4 mm in size because of an increased growth in size of follicles from the first FSH injection to sponge removal, an increase in the number of newly detected follicles from 12 to 36 h of the first FSH dose (p < 0.005) and a decrease in regression rate from 24 h (p < 0.001). The number of follicles 2-3 mm in size at first FSH dose (10.4 +/- 1.5) was positively correlated with the number of >/= 4 mm follicles at 0 h (19.0 +/- 2.7, p < 0.01). A higher number of >/= 4 mm follicles at 0 h was related with an earlier appearance of oestrus (31.5 +/- 1.5 h, p = 0.08) and LH surge (45.0 +/- 2.3 h, p < 0.005), and a higher ovulation rate (18.2 +/- 3.8, p < 0.005). On the other hand, the rate of embryo recovery was decreased in ewes with earlier preovulatory LH peaks (p < 0.005), with a shorter interval between oestrus and LH peak (p < 0.05).

Study Information

Provider

pubmed

Year

2002

DOI

10.1046/j.1439-0531.2002.00385.x